Routine panel of screening parameters for diagnostic assessment of blood disorders related to coagulation and fibrinolysis. These assays are being performed to determine the risk of exceeded bleeding (like childbirth or surgery) as well as to determine levels after heart attack.
| Type | Description | Product name / item |
|---|
| Clot assessment | For determination of prothrombin time (PT) by investigation of the extrinsic pathway | |
| Clot assessment | For determination of the activated partial thromboplastin time (aPTT) by investigation of the intrinsic pathway | Hemostat aPTT-EL |
| Clot assessment | For determination of the thrombin time (TT) for the basic screening profile | Hemostat Thrombin Time |
| Clot assessment | For determination of fibrin clot formation (Clauss Method) to identify fibrinogen defects | Hemostat Fibrinogen |
| Turbidimetric assay | For immunologic determination of D-dimer for exclusion of deep vein thrombosis of the leg or pulmonary embolism | Hemostat D-Dimer |
